Clinical Trials

NCT02981628 | ACTIVE_NOT_RECRUITING | PHASE2
80 participants

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2017-06-19
Completion:
2026-12-31
Conditions
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent B Lymphoblastic Lymphoma
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory B Lymphoblastic Lymphoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT02727803 | RECRUITING | PHASE2
100 participants

Personalized NK Cell Therapy in CBT

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2016-05-19
Completion:
2027-05-31
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Biphenotypic Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Acute Myeloid Leukemia With Variant MLL Translocations
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Chemotherapy-Related Leukemia
  • Chronic Myelomonocytic Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • ISS Stage II Plasma Cell Myeloma
  • ISS Stage III Plasma Cell Myeloma
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndrome With Excess Blasts
  • Myelodysplastic Syndrome With Gene Mutation
  • Myelodysplastic/Myeloproliferative Neoplasm
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Recurrent Hodgkin Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Adult Acute Lymphoblastic Leukemia
  • Secondary Acute Myeloid Leukemia
  • Therapy-Related Myelodysplastic Syndrome
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
  • RADIATION
  • PROCEDURE
No Results Yet
NCT02654119 | COMPLETED | PHASE2
20 participants

Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2015-12-11
Completion:
2025-12-08
Conditions
  • HER2 Positive Breast Carcinoma
  • Stage I Breast Cancer AJCC v7
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT01856192 | ACTIVE_NOT_RECRUITING | PHASE2
349 participants

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2013-08-27
Completion:
2020-03-26
Conditions
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT00114894 | COMPLETED | PHASE3
12 participants

Prevention of Jellyfish Stings

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-30
Start Date:
2004-04-30
Completion:
2006-01-31
Conditions
  • Bites and Stings
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page